Rho-kinase in patients with atherosclerosis: Effects of statins [HMG-CoA reductase inhibitors] a randomized clinical trial comparing ezetimibe/simvastatin and simvastatin

Trial Profile

Rho-kinase in patients with atherosclerosis: Effects of statins [HMG-CoA reductase inhibitors] a randomized clinical trial comparing ezetimibe/simvastatin and simvastatin

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Feb 2010

At a glance

  • Drugs Simvastatin (Primary) ; Ezetimibe; Ezetimibe/simvastatin
  • Indications Atherosclerosis; Dyslipidaemias; Lipid metabolism disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 29 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top